... University of Basel have developed nanocontainers having the ability to release their vasodilator content exclusively to diseased areas (see paper in Nature Nanotechnology: "Shear-stress sensitive lenticular vesicles for targeted drug delivery").

A nanotechnology time bomb to fight cardiovascular disease